No. 10 / 2025 Zealand Pharma submits Marketing Authorization Application to the European Medicines Agency for glepaglutide in ...

After the slimming effect of Ozempic and Zepbound earned billions for Novo Nordisk and Eli Lilly, another class of ...

The FDA designates 2 biosimilars as interchangeable, enhancing access to treatments for inflammatory diseases and multiple ...

The i Paper found mental healthcare professionals have accepted £1m from pharmaceutical companies since 2021 ...

Trans-Tasman drug developer Aft Pharmaceuticals is targeting lucrative niche diseases its Big Pharma rivals have ignored ...

European shares European shares were higher on Monday as investors reacted to U.S. President Donald Trump delaying the roll ...

Zealand Pharma A/S ADR stock grades by Barron's. View ZLDPY fundamental and sentiment analysis powered by MarketGrader.

Zealand Pharma A/S, a biotechnology company, has appointed Steven Johnson as Chief Development Officer.

BioMarin Pharmaceutical has agreed to acquire Inozyme Pharma for $4 ashare, or about $270 million in cash. The companies said Friday that their tie-up would strengthen BioMarin's enzyme therapies ...

A New Zealand parliamentary committee has recommended the unprecedented suspensions of three Māori lawmakers for performing a protest haka in the debating chamber WELLINGTON, New Zealand -- A New ...

The pharmaceutical industry, which is well known for its well-resourced lobbying campaigns, has a lesser-known tactic for influencing policy: bankrolling ostensibly independent nonprofit ...